Combining cognitive rehabilitation and therapy to help patients with post-COVID cognitive issues and depression
Integrated Cognitive Rehabilitation and Cognitive Behavioral Therapy Intervention for patients with Post-COVID-19 Cognitive Impairment and Depression
This study is looking to create and try out a new program that helps people who are feeling forgetful and down after having COVID-19, making sure it works well for everyone, no matter their background.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11055114 on NIH RePORTER |
What this research studies
This research aims to develop and test a new intervention that combines cognitive rehabilitation and cognitive behavioral therapy specifically for patients experiencing cognitive impairment and depression after COVID-19. The approach will be tailored to meet the needs of ethnoculturally diverse patients, ensuring that the intervention is relevant and effective for a wide range of individuals. The research will involve gathering insights from patients through focus groups and interviews to refine the intervention, followed by a pilot trial to assess its feasibility and initial effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 who are experiencing cognitive impairment and depression as a result of COVID-19.
Not a fit: Patients who do not have cognitive impairment or depression related to COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve cognitive function and mental health for patients suffering from post-COVID cognitive impairment and depression.
How similar studies have performed: Previous research has shown promise in using cognitive rehabilitation and therapy for cognitive and mental health issues, suggesting that this integrated approach could be effective.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Becker, Jacqueline Helcer — Icahn School of Medicine at Mount Sinai
- Study coordinator: Becker, Jacqueline Helcer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.